These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11707769)

  • 41. Treatment of sarin exposure.
    Schier JG; Hoffman RS
    JAMA; 2004 Jan; 291(2):182; author reply 182-3. PubMed ID: 14722139
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical manifestations of sarin nerve gas exposure.
    Lee EC
    JAMA; 2003 Aug; 290(5):659-62. PubMed ID: 12902371
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical predictors of bioterrorism-related inhalational anthrax.
    Kyriacou DN; Stein AC; Yarnold PR; Courtney DM; Nelson RR; Noskin GA; Handler JA; Frerichs RR
    Lancet; 2004 Jul 31-Aug 6; 364(9432):449-52. PubMed ID: 15288744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effective management of sarin exposure: simulation case scenario.
    Hanson NA; Hobbs E; Taekman JM
    Simul Healthc; 2008; 3(3):204-7. PubMed ID: 19088664
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of sarin exposure.
    Krivoy A; Layish I; Rotman E; Yehezkelli Y
    JAMA; 2004 Jan; 291(2):181; author reply 182-3. PubMed ID: 14722138
    [No Abstract]   [Full Text] [Related]  

  • 46. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhalational anthrax in a vaccinated soldier.
    Sykes A; Brooks T; Dusmet M; Nicholson AG; Hansell DM; Wilson R
    Eur Respir J; 2013 Jul; 42(1):285-7. PubMed ID: 23813313
    [No Abstract]   [Full Text] [Related]  

  • 48. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001.
    JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of sarin exposure.
    DeBalli P; Cook DR
    JAMA; 2004 Jan; 291(2):181-2; author reply 182-3. PubMed ID: 14722137
    [No Abstract]   [Full Text] [Related]  

  • 50. Bioterrorism: introduction and major agents.
    Kemp C
    J Am Acad Nurse Pract; 2001 Nov; 13(11):483-91. PubMed ID: 11930512
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical predictors of bioterrorism-related inhalational anthrax.
    Tepper M; Whitehead J
    Lancet; 2005 Jan 15-21; 365(9455):214; author reply 215. PubMed ID: 15652600
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective.
    Patt HA; Feigin RD
    Pediatrics; 2002 Apr; 109(4):685-92. PubMed ID: 11927716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Syrian gas attack reinforces need for better anti-sarin drugs.
    Dolgin E
    Nat Med; 2013 Oct; 19(10):1194-5. PubMed ID: 24100968
    [No Abstract]   [Full Text] [Related]  

  • 54. Vaccines and bioterrorism: smallpox and anthrax.
    Kimmel SR; Mahoney MC; Zimmerman RK
    J Fam Pract; 2003 Jan; 52(1 Suppl):S56-61. PubMed ID: 12556279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical predictors of bioterrorism-related inhalational anthrax.
    Gair R
    Lancet; 2005 Jan 15-21; 365(9455):214-5; author reply 215. PubMed ID: 15652599
    [No Abstract]   [Full Text] [Related]  

  • 56. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of sarin.
    Sharp D
    Lancet; 2006 Jan; 367(9505):95-7. PubMed ID: 16413861
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of inhalational anthrax.
    Porter RS
    JAMA; 2002 Feb; 287(8):984; author reply 985. PubMed ID: 11866635
    [No Abstract]   [Full Text] [Related]  

  • 59. Radiology of biological weapons--old and the new?
    Ketai L; Tchoyoson Lim CC
    Semin Roentgenol; 2007 Jan; 42(1):49-59. PubMed ID: 17174174
    [No Abstract]   [Full Text] [Related]  

  • 60. Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes.
    Lewine JD; Weber W; Gigliotti A; McDonald JD; Doyle-Eisele M; Bangera N; Paulson K; Magcalas C; Hamilton DA; Garcia E; Raulli R; Laney J
    Neurotoxicology; 2018 Dec; 69():37-46. PubMed ID: 30172622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.